On 28-29-30-31 October at the FUTURE LIVE headquarters in Affi (VR), the presentation to the entire network of the Company’s medical advisors was held of PEALGYL®, a product based on an innovative formulation of PEA ( Palmitoylethanolamide) and PIDOMAGNESIUM® (magnesium pidolate), characterized by a specific adjuvant action in the resolution of long-term pelvic pain.
PEALGYL® uses a particular formulation of PEA capable of significantly improving its solubility and bioavailability, associated with an organic salt, magnesium pidolate, able to exert the best muscle relaxant action on pelvic tissues.
PEALGYL® is available in packs of 20 sachets to be dispersed in a glass of water.
FUTURE LIVE is currently engaged in the presentation of PEALGYL® to medical specialists throughout the national territory.
